日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Clinical impact of BioFire Blood Culture Identification 2 implementation in patients with Staphylococcus bacteremia

BioFire血液培养鉴定2技术在葡萄球菌菌血症患者中的临床应用影响

期刊:Microbiology Spectrum
影响因子:3.8
doi:10.1128/spectrum.01093-25
Duell, Colin H; Ackley, Tyler; Linder, Kristin E; Kuti, Joseph L; Castle, Alivia; Li, Rosanna
发表日期：2026
文献求助 收藏

Echocardiographic evaluations of right ventricular functions and dimensions in children with bronchial asthma in Ile-Ife, Nigeria

在尼日利亚伊费市，对患有支气管哮喘的儿童进行右心室功能和尺寸的超声心动图评估

期刊:BMC Cardiovascular Disorders
影响因子:2.3
doi:10.1186/s12872-026-05718-8
Adetola, Hammed Hassan; Kuti, Bankole Peter; Ogunlesi, Tinuade Adetutu; Okeniyi, John Akintunde; Obiajunwa, Perpetua Okwuchi; Kareem, Abiodun John
哮喘
发表日期：2026
文献求助 收藏

Point-Counterpoint: Cascade reporting-useful tool to support antimicrobial stewardship, or dangerously misleading

正反观点：级联报告——是支持抗菌药物管理的有用工具，还是具有危险误导性的工具？

期刊:Journal of Clinical Microbiology
影响因子:5.4
doi:10.1128/jcm.01708-24
Kuti, Joseph L; Lutgring, Joseph D; Simner, Patricia J; Naccache, Samia N; Heil, Emily L
发表日期：2025
文献求助 收藏

Ex vivo assessment of sulbactam-durlobactam clearance during continuous renal replacement therapy to guide dosing recommendations

在连续性肾脏替代治疗期间，通过体外评估舒巴坦-度洛巴坦的清除率来指导给药建议

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/aac.01674-23
Abouelhassan, Yasmeen; Shen, Yuwei; Chen, April; Ye, Xiaoyi; Nicolau, David P; Kuti, Joseph L
发表日期：2025
文献求助 收藏

Cefiderocol pharmacokinetics during acute pulmonary exacerbations in hospitalized adult persons with cystic fibrosis

头孢地洛在住院成年囊性纤维化患者急性肺部加重期间的药代动力学

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/aac.01539-24
Koenig, Christina; Monogue, Marguerite L; Shields, Ryan K; Sakon, Colleen M; Fratoni, Andrew J; Roenfanz, Hanna F; Finklea, James D; Pope, James S; Nicolau, David P; Kuti, Joseph L
发表日期：2025
文献求助 收藏

Ex vivo assessment and simulation to guide cefepime-taniborbactam dosing recommendations for patients receiving continuous renal replacement therapy

体外评估和模拟指导接受连续性肾脏替代治疗患者的头孢吡肟-他尼博巴坦给药方案建议

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/aac.00061-25
Fouad, Aliaa; McGrath, Cole; Buyukyanbolu, Ecem; Kuti, Joseph L
发表日期：2025
文献求助 收藏

Impact of an electronic antibiotic time-out best practice alert on antibiotic use and prescribing behavior in hospitalized patients

电子抗生素暂停使用最佳实践警报对住院患者抗生素使用和处方行为的影响

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/aac.01680-24
Ackley, Tyler; Kuti, Joseph; Bilinskaya, Anastasia; Linder, Kristin; Dempsey, Casey
发表日期：2025
文献求助 收藏

In vitro persistence of clinical methicillin-resistant Staphylococcus aureus isolates from bone and joint infections after exposure to daptomycin, telavancin, and vancomycin

临床分离的耐甲氧西林金黄色葡萄球菌（MRSA）在骨和关节感染中暴露于达托霉素、特拉万星和万古霉素后的体外持久性

期刊:Microbiology Spectrum
影响因子:3.8
doi:10.1128/spectrum.01576-25
Fouad, Aliaa; Kuti, Joseph L; Gill, Christian M
炎症/感染
发表日期：2025
文献求助 收藏

Pharmacokinetics of continuous infusion ceftolozane/tazobactam in two patients with extensive total body surface area burns

两例全身大面积烧伤患者持续输注头孢洛扎/他唑巴坦的药代动力学研究

期刊:Pharmacotherapy
影响因子:3.4
doi:10.1002/phar.70019
Olivet, Jay D; Amerson-Brown, Megan; Calix, Juan J; Graffice, Emma; Kilpatrick, Tyson; Roenfanz, Hanna F; Nicolau, David P; Kuti, Joseph L; Brown, Matthew L
发表日期：2025
文献求助 收藏

Pharmacokinetic and pharmacodynamic evaluation of sulbactam-durlobactam in a critically ill patient on continuous venovenous hemofiltration infected with carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex.

对接受持续静脉-静脉血液滤过治疗的重症患者进行舒巴坦-度洛巴坦的药代动力学和药效学评价，该患者感染了耐碳青霉烯类鲍曼不动杆菌-钙醋酸杆菌复合群

期刊:Pharmacotherapy
影响因子:3.4
doi:10.1002/phar.70027
Kufel Wesley D, Zeineddine Nabil, Fouad Aliaa, Roenfanz Hanna F, Shields Ryan K, Kline Ellen G, Warner Jameson, Hanrahan Kathleen, Kuti Joseph L
微生物学
发表日期：2025
文献求助 收藏